Ladprao General Hospital Public Company Limited (BK:LPH) — Market Cap & Net Worth
Market Cap & Net Worth: Ladprao General Hospital Public Company Limited (LPH)
Ladprao General Hospital Public Company Limited (BK:LPH) has a market capitalization of $80.34 Million (฿2.58 Billion) as of September 22, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #20157 globally and #314 in its home market, demonstrating a -1.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ladprao General Hospital Public Company Limited's stock price ฿3.58 by its total outstanding shares 720000000 (720.00 Million). Also see LPH current and non-current assets for a full breakdown of the balance sheet.
Ladprao General Hospital Public Company Limited Market Cap History: 2015 to 2026
Ladprao General Hospital Public Company Limited's market capitalization history from 2015 to 2026. Data shows change from $102.22 Million to $80.34 Million (-3.39% CAGR). Also see Ladprao General Hospital Public Company (LPH) cash conversion ratio for how efficiently the company converts equity into cash flow.
Ladprao General Hospital Public Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ladprao General Hospital Public Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Ladprao General Hospital Public Company (LPH) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.04x
Ladprao General Hospital Public Company Limited's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.23x
Ladprao General Hospital Public Company Limited's market cap is 1.23 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $102.22 Million | $1.24 Billion | $100.45 Million | 0.08x | 1.02x |
| 2016 | $162.10 Million | $1.33 Billion | $155.90 Million | 0.12x | 1.04x |
| 2017 | $127.86 Million | $1.43 Billion | $193.83 Million | 0.09x | 0.66x |
| 2018 | $101.41 Million | $1.53 Billion | $156.95 Million | 0.07x | 0.65x |
| 2019 | $89.51 Million | $1.58 Billion | $110.49 Million | 0.06x | 0.81x |
| 2020 | $87.20 Million | $1.80 Billion | $142.89 Million | 0.05x | 0.61x |
| 2021 | $118.43 Million | $2.50 Billion | $464.52 Million | 0.05x | 0.25x |
| 2022 | $118.48 Million | $2.42 Billion | $322.91 Million | 0.05x | 0.37x |
| 2023 | $108.08 Million | $2.23 Billion | $63.55 Million | 0.05x | 1.70x |
| 2024 | $96.50 Million | $2.40 Billion | $78.18 Million | 0.04x | 1.23x |
Competitor Companies of LPH by Market Capitalization
Companies near Ladprao General Hospital Public Company Limited in the global market cap rankings as of September 22, 2026. Review Ladprao General Hospital Public Company (LPH) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Ladprao General Hospital Public Company Limited by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #291 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #918 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #997 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1238 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #291 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $425.97 |
| #918 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.10 |
| #997 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1238 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.97 |
Ladprao General Hospital Public Company Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Ladprao General Hospital Public Company Limited's market cap moved from $102.22 Million to $ 80.34 Million, with a yearly change of -3.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ฿80.34 Million | -3.76% |
| 2025 | ฿83.48 Million | -13.49% |
| 2024 | ฿96.50 Million | -10.72% |
| 2023 | ฿108.08 Million | -8.77% |
| 2022 | ฿118.48 Million | +0.04% |
| 2021 | ฿118.43 Million | +35.82% |
| 2020 | ฿87.20 Million | -2.58% |
| 2019 | ฿89.51 Million | -11.74% |
| 2018 | ฿101.41 Million | -20.69% |
| 2017 | ฿127.86 Million | -21.12% |
| 2016 | ฿162.10 Million | +58.58% |
| 2015 | ฿102.22 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 22nd, 2026 the market cap of Ladprao General Hospital Public Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $80.34 Million USD |
| MoneyControl | $80.34 Million USD |
| MarketWatch | $80.34 Million USD |
| marketcap.company | $80.34 Million USD |
| Reuters | $80.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ladprao General Hospital Public Company Limited
Ladprao General Hospital Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. It operates through two segments, Hospital, and Scientific Testing and Research segments. The company operates social security, bone and joint, pediatric, aesthetics and laser, health screening, dental, dermatology, cancer, gastrointestinal and liver, surgery, neurology, … Read more